Barbara Oil Co. Makes New $12.06 Million Investment in Globe Life Inc. $GL

Key Points

• Barbara Oil Co. acquired 67,500 Globe Life shares worth approximately $12.06 million, making the insurer its fifth-largest holding and representing 4.1% of its portfolio. Institutional investors collectively own 81.61% of Globe Life.
• Globe Life reported quarterly revenue of $1.60 billion, up 8% year over year, but earnings per share of $3.61 fell short of the $3.67 analyst consensus. The company issued fiscal 2026 EPS guidance of $15.55–$15.95.
• The insurer declared a quarterly dividend of $0.33 and authorized a $2.5 billion share-repurchase program covering up to 17.7% of outstanding shares. Analysts maintain a “Moderate Buy” consensus with an average price target of $191.67, while company insiders have sold shares recently.

Barbara Oil Co. purchased a new position in Globe Life Inc. (NYSE:GL - Free Report) in the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 67,500 shares of the company's stock, valued at approximately $12,061,000. Globe Life accounts for 4.1% of Barbara Oil Co.'s portfolio, making the stock its 5th largest holding. Barbara Oil Co. owned 0.09% of Globe Life as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. CYBER HORNET ETFs LLC acquired a new stake in Globe Life in the second quarter worth approximately $28,000. Hilton Head Capital Partners LLC acquired a new position in shares of Globe Life during the 4th quarter valued at $30,000. MUFG Securities EMEA plc bought a new stake in shares of Globe Life in the 2nd quarter worth $31,000. Torren Management LLC bought a new stake in shares of Globe Life in the 4th quarter worth $37,000. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Globe Life in the second quarter valued at $39,000. Institutional investors and hedge funds own 81.61% of the company's stock.

Globe Life Stock Down 0.0%

Shares of Globe Life stock opened at $171.07 on Monday. Globe Life Inc. has a 12-month low of $127.85 and a 12-month high of $191.55. The firm has a market capitalization of $13.15 billion, a PE ratio of 11.36 and a beta of 0.48. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The stock's fifty day moving average is $178.36 and its 200-day moving average is $158.62.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts' consensus estimates of $3.67 by ($0.06). The company had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The company's revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the business earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Equities analysts anticipate that Globe Life Inc. will post 15.71 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life's dividend payout ratio (DPR) is presently 8.76%.

Globe Life announced that its Board of Directors has initiated a stock repurchase program on Monday, August 10th that allows the company to repurchase $2.50 billion in shares. This repurchase authorization allows the company to purchase up to 17.7% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on GL. Weiss Ratings cut Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a research note on Monday, July 20th. Jefferies Financial Group boosted their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a "hold" rating in a research report on Friday, July 10th. JPMorgan Chase & Co. raised their price objective on shares of Globe Life from $181.00 to $201.00 and gave the company an "overweight" rating in a research report on Tuesday, July 21st. Piper Sandler raised their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an "overweight" rating in a research report on Wednesday, July 15th. Finally, Wells Fargo & Company lifted their price objective on shares of Globe Life from $172.00 to $193.00 and gave the stock an "overweight" rating in a research note on Thursday, July 9th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat, Globe Life has a consensus rating of "Moderate Buy" and an average price target of $191.67.

Insider Buying and Selling

In related news, Director Cheryl Alston sold 8,258 shares of the company's stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $179.24, for a total value of $1,480,163.92. Following the completion of the sale, the director owned 16,621 shares in the company, valued at approximately $2,979,148.04. This represents a 33.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO James Matthew Darden sold 50,000 shares of the firm's stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $182.43, for a total transaction of $9,121,500.00. Following the completion of the transaction, the chief executive officer directly owned 58,451 shares of the company's stock, valued at $10,663,215.93. This represents a 46.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 151,908 shares of company stock valued at $27,239,981. Company insiders own 2.11% of the company's stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source